“
William Edward and
Ottiwell Jones
The character of the meeting has been preserved with down-to-earth speakers, excellent discussion, long enough time, and great access to the speakers.”
Don D’Amico
| Founders Lectures | ||||
|---|---|---|---|---|
 | ||||
| 2024 | K. Bailey Freund, MD | Key OCT Signatures and Their Histologic Correlates Which Every Clinician Should Recognize | ||
| 2023 | Gregg T. Kokame, MD, MMM | Management of Exudative Macular Degeneration Based on Anatomic Subtypes | ||
| 2022 | H. Culver Boldt, MD | Surgical Training: Advances After Three Decades | ||
| 2021 | Dennis P. Han, MD | Anti-VEGF Therapy of Neovascular AMD with Advanced Visual Loss: Going Where Few Randomized Trials Have Gone Before | ||
| 2020 | Glenn J. Jaffe, MD | Surgical Rounds | ||
| 2019 | Allen C. Ho, MD | Gene Therapy for Neovascular AMD 2019: Pitfalls and Promise | ||
| 2018 | Maria H. Berrocal, MD | Pearls in the Surgical Management of Complications of Diabetic Retinopathy | ||
| 2017 | Mark S. Humayun, MD, PhD | The Road to Developing Bioelectronics for Ophthalmology | ||
| 2016 | Mark W. Johnson, MD | Ocriplasmin Retinopathy: Characteristics, Mechanism, Incidence, and Reversibility | ||
| 2015 | Dean Eliott, MD | Proliferative Vitreoretinopathy: Principles and Controversies | ||
| 2014 | Carl D. Regillo, MD | Anti-VEGF Maintenance Therapy for Neovascular AMD | ||
| 2013 | Joan W. Miller, MD | Current and Future Therapies of AMD | ||
| 2012 | Steven T. Charles, MD | 25G Vitrectomy without Scleral Buckling for RRD, PVR, and Giant Breaks | ||